PA
Perceptive Advisors’s Immunovant IMVT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $34.2M | Sell |
2,137,890
-706,182
| -25% | -$11.3M | 1.27% | 22 |
|
2025
Q1 | $48.6M | Buy |
2,844,072
+704,873
| +33% | +$12M | 1.72% | 14 |
|
2024
Q4 | $53M | Sell |
2,139,199
-239,563
| -10% | -$5.93M | 1.46% | 22 |
|
2024
Q3 | $67.8M | Buy |
2,378,762
+454,976
| +24% | +$13M | 1.43% | 22 |
|
2024
Q2 | $50.8M | Sell |
1,923,786
-1,039,426
| -35% | -$27.4M | 1.22% | 24 |
|
2024
Q1 | $95.7M | Buy |
2,963,212
+635,130
| +27% | +$20.5M | 1.68% | 17 |
|
2023
Q4 | $98.1M | Sell |
2,328,082
-1,486,609
| -39% | -$62.6M | 2.19% | 9 |
|
2023
Q3 | $146M | Buy |
3,814,691
+1,290,908
| +51% | +$49.6M | 4.88% | 3 |
|
2023
Q2 | $47.9M | Buy |
2,523,783
+1,231,925
| +95% | +$23.4M | 1.39% | 20 |
|
2023
Q1 | $20M | Buy |
1,291,858
+1,141,858
| +761% | +$17.7M | 0.59% | 44 |
|
2022
Q4 | $2.66M | Buy |
+150,000
| New | +$2.66M | 0.07% | 81 |
|
2021
Q1 | – | Sell |
-1,400,000
| Closed | -$64.7M | – | 148 |
|
2020
Q4 | $64.7M | Hold |
1,400,000
| – | – | 0.69% | 38 |
|
2020
Q3 | $49.3M | Buy |
1,400,000
+300,000
| +27% | +$10.6M | 0.72% | 37 |
|
2020
Q2 | $26.8M | Buy |
+1,100,000
| New | +$26.8M | 0.43% | 53 |
|